Skip to main content

Together we are beating cancer

Donate now
  • For Researchers

Welcome to our new committee chairs

by Phil Prime | Interview

22 November 2022

0 comments 0 comments


We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

Kairbaan Hodivala-Dilke is the new Chair of our Research Careers Committee. Her research group investigates the molecular mechanisms underlying stromal contributions to tumour growth and therapy efficacy.

Simon Boulton is Principal Group Leader of the Double Strand Break Repair (DSB) Metabolism Laboratory at the Francis Crick Institute and co-founder and Vice President of science strategy of biotech company Artios Pharma. Simon joins as Chair of our Discovery Research Committee.


Kairbaan Hodivala-DilkeKairbaan Hodivala-Dilke, Deputy Director Barts Cancer Institute and Professor of the tumour microenvironment.

Chair of CRUK’s Research Careers Committee

Kairbaan Hodivala-Dilke is the Deputy Director of Barts Cancer Institute, part of the Cancer Research UK City of London Centre. Over the course of her career, Kairbaan has made significant contributions to the understanding of the cellular and molecular biology of the tumour microenvironment.

She now heads up the Centre for Tumour Microenvironments at Barts where she’s leading research into how the tumour microenvironment forms and how the community of cells and proteins within it interact.

Understanding the interplay between the tumour microenvironment and blood vessels is at the heart of the team’s plan to translate their insights into benefits for people with cancer. Kairbaan’s team is currently investigating the role of vascular promotion, or improved blood flow and drug delivery into tumours, to improve the efficacy of cancer therapies.

Learn more about our Research Careers Committee

Simon Boulton Simon Boulton FMedSci FRS, Principal Group Leader and Assistant Research Director of Translation, Francis Crick Institute. Co-founder and Vice President of Science Strategy, Artios Pharma.

Chair of CRUK’s Discovery Research Committee

Simon Boulton is a leader in the field of DNA damage sensing, repair and telomere maintenance. He is principal group leader and assistant research director of translation at the Francis Crick Institute and Director of Radnet, City of London, a CRUK initiative focused on improving radiation treatment for cancer patients.

Simon’s work focuses on understanding DNA repair and telomere maintenance and how failures in these processes leads to cancer and other diseases. Over his career, he has discovered novel DNA repair factors linked to human disease, defined the molecular basis through which these factors act, and has uncovered mechanisms by which structures called telomeres protect and maintain chromosomes ends.

Learn more about our Discovery Research Committee